𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells

✍ Scribed by Feng Su; Katherine R. Kozak; Harvey Herschman; Srinivasa T. Reddy; Robin Farias-Eisner


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
308 KB
Volume
85
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Rat PC12 pheochromocytoma cells treated with nerve growth factor (NGF) extend “neurites” and initiate a neuronal differentiation pathway. Although neurotrophins, growth factors [e.g., epidermal growth factor (EGF)], and other ligands induce many common primary response genes (PRGs) in PC12 cells, a unique PRG subset is induced preferentially by NGF. Expression of one NGF preferentially induced gene, urokinase plasminogen activator receptor (UPAR), is required for NGF‐induced neurite extension and neuronal differentiation. A 2.1‐kb fragment of the rat UPAR 5′ regulatory region confers differential expression by NGF versus EGF, following transfection of a luciferase reporter construct into PC12 cells. Deletion studies identified a region between −100 and −50 nucleotides from the transcription start site as the region conferring preferential NGF induction. Sequence comparisons among rat, human, and murine UPAR promoters identified two common potential regulatory regions. Site‐directed mutation identified an activator protein‐1 (AP‐1) region between −66 and −72 bp, required for luciferase reporter activation by NGF. Electrophoretic mobility shift and antibody supershift assays demonstrated that specific Fos and Jun family members preferentially bind to this site following NGF treatment. We conclude that preferential activation of transcription factor binding at this AP‐1 site mediates preferential NGF activation of the UPAR gene. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Lysophosphatidic acid promotes cell inva
✍ Mi Ha Kim; Jung Sun Park; Hee Jung Chang; Min Kyung Baek; Hyeong Rok Kim; Boo Ah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

## Abstract There is a strong correlation between the overexpression of urokinase‐type plasminogen activator receptor (uPAR) and gastric cancer invasion. This study examined the effect of phospholipid lysophosphatidic acid (LPA) on uPAR expression in human gastric cancer AGS cells and the underlyin

Urokinase plasminogen activator receptor
✍ Jian-Ming Gu; Anthony Johns; John Morser; William P. Dole; David R. Greaves; Gar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract The urokinase plasminogen activator receptor (uPAR) regulates macrophage adhesion and migration by binding directly to matrix proteins and signaling through integrin complexes. In this study, we examined the role of uPAR on macrophage infiltration into the vascular wall. Stable murine m

Comparative evaluation of urokinase-type
✍ Alice Hemsen; Lutz Riethdorf; Nils Brünner; Jürgen Berger; Sebastian Ebel; Chris 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 233 KB 👁 1 views

## Abstract The urokinase‐type plasminogen activator receptor (uPAR, CD87) plays a central role in the plasminogen activation cascade, which participates in extracellular matrix degradation, cell migration and invasion. Here we performed a comprehensive immmunohistochemical evaluation of uPAR expre

Urinary levels of urokinase-type plasmin
✍ Roberto Casella; Shahrokh F. Shariat; Mara A. Monoski; Seth P. Lerner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Background: The authors found previously that plasma levels of urokinase-type plasminogen activator (upa) and its receptor (upar) were elevated in patients with bladder carcinoma and were associated with features of biologically aggressive disease. in the current study, they tested the hypothesi